• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人参皂苷Rg1通过SIRT1/PINK1/ Parkin介导的线粒体自噬预防心力衰竭中的心脏重塑。

Ginsenoside Rg1 Protects against Cardiac Remodeling in Heart Failure via SIRT1/PINK1/Parkin-Mediated Mitophagy.

作者信息

Guan Sibin, Xin Yuanfeng, Ding Yagang, Zhang Qingliu, Han Wei

机构信息

Department of Heart Failure, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China.

Department of Cardiovascular Surgery, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China.

出版信息

Chem Biodivers. 2023 Feb;20(2):e202200730. doi: 10.1002/cbdv.202200730. Epub 2023 Jan 24.

DOI:10.1002/cbdv.202200730
PMID:36639922
Abstract

Adverse cardiac remodeling may lead to the development and progression of heart failure, which is lack of effective clinical treatment. Ginsenoside Rg1 (GRg1), a primary ingredient of Panax ginseng, protects against diverse cardiovascular disease, but its effects on cardiac remodeling remain unclear. Thus, we investigated the protective effect and mechanism of GRg1 on cardiac remodeling after myocardial infarction. GRg1 significantly ameliorated cardiac remodeling in mice with left anterior descending coronary artery ligation, reflected by reduced left ventricular dilation and decreased cardiac fibrosis, accompanied by improved cardiac function. Mechanistically, GRg1 considerably increased mitophagosomes formation, ameliorated cardiac mitochondria damage, and enhanced SIRT1/PINK1/Parkin-mediated mitophagy during cardiac remodeling. Consistently, GRg1 increased cell viability and attenuated apoptosis and fibrotic responses in H O -treated H9c2 cells by promoting the SIRT1/PINK1/Parkin axis. Furthermore, SIRT1-specific inhibitor (EX527) or the use of small interfering RNA against Parkin abolished the protective effect of GRg1 in vitro. These findings reveal a novel mechanism of GRg1 alleviating cardiac remodeling via enhancing SIRT1/PINK1/Parkin-mediated mitophagy.

摘要

不良心脏重塑可能导致心力衰竭的发生和发展,而心力衰竭缺乏有效的临床治疗方法。人参皂苷Rg1(GRg1)是人参的主要成分,可预防多种心血管疾病,但其对心脏重塑的影响尚不清楚。因此,我们研究了GRg1对心肌梗死后心脏重塑的保护作用及其机制。GRg1显著改善了左冠状动脉前降支结扎小鼠的心脏重塑,表现为左心室扩张减轻和心脏纤维化减少,并伴有心脏功能改善。机制上,GRg1在心脏重塑过程中显著增加了线粒体自噬体的形成,改善了心脏线粒体损伤,并增强了SIRT1/PINK1/Parkin介导的线粒体自噬。同样,GRg1通过促进SIRT1/PINK1/Parkin轴增加了过氧化氢处理的H9c2细胞的活力,减轻了细胞凋亡和纤维化反应。此外,SIRT1特异性抑制剂(EX527)或使用针对Parkin的小干扰RNA消除了GRg1在体外的保护作用。这些发现揭示了GRg1通过增强SIRT1/PINK1/Parkin介导的线粒体自噬减轻心脏重塑的新机制。

相似文献

1
Ginsenoside Rg1 Protects against Cardiac Remodeling in Heart Failure via SIRT1/PINK1/Parkin-Mediated Mitophagy.人参皂苷Rg1通过SIRT1/PINK1/ Parkin介导的线粒体自噬预防心力衰竭中的心脏重塑。
Chem Biodivers. 2023 Feb;20(2):e202200730. doi: 10.1002/cbdv.202200730. Epub 2023 Jan 24.
2
Nuanxinkang prevents the development of myocardial infarction-induced chronic heart failure by promoting PINK1/Parkin-mediated mitophagy.暖心康通过促进 PINK1/Parkin 介导的线粒体自噬来防止心肌梗死诱导的慢性心力衰竭的发展。
Phytomedicine. 2023 Jan;108:154494. doi: 10.1016/j.phymed.2022.154494. Epub 2022 Oct 7.
3
Treadmill Exercise Improves PINK1/Parkin-Mediated Mitophagy Activity Against Alzheimer's Disease Pathologies by Upregulated SIRT1-FOXO1/3 Axis in APP/PS1 Mice. treadmill 运动通过上调 APP/PS1 小鼠中的 SIRT1-FOXO1/3 轴改善 PINK1/Parkin 介导的对阿尔茨海默病病理的自噬活性。
Mol Neurobiol. 2023 Jan;60(1):277-291. doi: 10.1007/s12035-022-03035-7. Epub 2022 Oct 20.
4
Melatonin ameliorates excessive PINK1/Parkin-mediated mitophagy by enhancing SIRT1 expression in granulosa cells of PCOS.褪黑素通过增强 PCOS 颗粒细胞中 SIRT1 的表达来改善过多的 PINK1/Parkin 介导的细胞自噬。
Am J Physiol Endocrinol Metab. 2020 Jul 1;319(1):E91-E101. doi: 10.1152/ajpendo.00006.2020. Epub 2020 Apr 28.
5
Apelin-36 Protects HT22 Cells Against Oxygen-Glucose Deprivation/Reperfusion-Induced Oxidative Stress and Mitochondrial Dysfunction by Promoting SIRT1-Mediated PINK1/Parkin-Dependent Mitophagy.Apelin-36 通过促进 SIRT1 介导的 PINK1/Parkin 依赖性线粒体自噬来保护 HT22 细胞免受氧葡萄糖剥夺/再灌注诱导的氧化应激和线粒体功能障碍。
Neurotox Res. 2021 Jun;39(3):740-753. doi: 10.1007/s12640-021-00338-w. Epub 2021 Feb 13.
6
CERKL alleviates ischemia reperfusion-induced nervous system injury through modulating the SIRT1/PINK1/Parkin pathway and mitophagy induction.CERKL 通过调节 SIRT1/PINK1/Parkin 通路和诱导自噬来减轻缺血再灌注引起的神经系统损伤。
Biol Chem. 2022 Mar 2;403(7):691-701. doi: 10.1515/hsz-2021-0411. Print 2022 Jun 27.
7
Hypoxia-induced PINK1/Parkin-mediated mitophagy promotes pulmonary vascular remodeling.低氧诱导的 PINK1/Parkin 介导的线粒体自噬促进肺血管重构。
Biochem Biophys Res Commun. 2021 Jan 1;534:568-575. doi: 10.1016/j.bbrc.2020.11.040. Epub 2020 Nov 22.
8
Acetylcholine Attenuates Hypoxia/Reoxygenation Injury by Inducing Mitophagy Through PINK1/Parkin Signal Pathway in H9c2 Cells.乙酰胆碱通过PINK1/Parkin信号通路诱导H9c2细胞发生线粒体自噬从而减轻缺氧/复氧损伤。
J Cell Physiol. 2016 May;231(5):1171-81. doi: 10.1002/jcp.25215. Epub 2015 Oct 23.
9
PTEN-Induced Putative Kinase 1 (PINK1)/Parkin-Mediated Mitophagy Protects PC12 Cells Against Cisplatin-Induced Neurotoxicity.PTEN 诱导的假定激酶 1(PINK1)/Parkin 介导的线粒体自噬可保护 PC12 细胞免受顺铂诱导的神经毒性。
Med Sci Monit. 2019 Nov 21;25:8797-8806. doi: 10.12659/MSM.918536.
10
α-Ketoglutarate improves cardiac insufficiency through NAD-SIRT1 signaling-mediated mitophagy and ferroptosis in pressure overload-induced mice.α-酮戊二酸通过 NAD-SIRT1 信号转导介导的自噬和铁死亡改善压力超负荷诱导的小鼠心功能不全。
Mol Med. 2024 Jan 22;30(1):15. doi: 10.1186/s10020-024-00783-1.

引用本文的文献

1
Mitophagy: a novel avenue for herbal medicines alleviating myocardial ischemia/reperfusion injury.线粒体自噬:草药减轻心肌缺血/再灌注损伤的新途径。
Apoptosis. 2025 Sep 12. doi: 10.1007/s10495-025-02178-x.
2
Therapeutic Potential of Ginsenosides in Anthracycline-Induced Cardiotoxicity.人参皂苷在蒽环类药物诱导的心脏毒性中的治疗潜力。
Molecules. 2025 Jun 10;30(12):2527. doi: 10.3390/molecules30122527.
3
Chinese medicine targets cellular autophagy against cardiovascular diseases: research progress and future prospects.中医药针对细胞自噬防治心血管疾病的研究进展与未来展望
Front Cardiovasc Med. 2025 May 26;12:1585407. doi: 10.3389/fcvm.2025.1585407. eCollection 2025.
4
Advances in pharmacological research on myocardial remodeling agents: A decade in review.心肌重塑药物的药理学研究进展:十年回顾
Medicine (Baltimore). 2025 Jun 6;104(23):e42757. doi: 10.1097/MD.0000000000042757.
5
Ginsenoside Rg1 Downregulates miR-9-5p Expression to Modulate SIRT1-Mediated Mitochondrial Dysfunction and Ameliorate Alzheimer's Disease.人参皂苷Rg1下调miR-9-5p表达以调节SIRT1介导的线粒体功能障碍并改善阿尔茨海默病。
Mol Neurobiol. 2025 Jun 6. doi: 10.1007/s12035-025-05073-3.
6
Roles and mechanisms of ginsenoside Rg1 in coronary artery disease: Progress and perspectives.人参皂苷Rg1在冠状动脉疾病中的作用及机制:研究进展与展望
J Ginseng Res. 2025 May;49(3):225-236. doi: 10.1016/j.jgr.2025.02.003. Epub 2025 Feb 18.
7
Zinc Alleviates Diabetic Muscle Atrophy via Modulation of the SIRT1/FoxO1 Autophagy Pathway Through GPR39.锌通过GPR39调节SIRT1/FoxO1自噬途径减轻糖尿病性肌肉萎缩。
J Cachexia Sarcopenia Muscle. 2025 Apr;16(2):e13771. doi: 10.1002/jcsm.13771.
8
Ginsenoside Rg1 improves hypoxia-induced pulmonary vascular endothelial dysfunction through TXNIP/NLRP3 pathway-modulated mitophagy.人参皂苷Rg1通过TXNIP/NLRP3通路调节的线粒体自噬改善缺氧诱导的肺血管内皮功能障碍。
J Ginseng Res. 2025 Jan;49(1):80-91. doi: 10.1016/j.jgr.2024.10.002. Epub 2024 Oct 24.
9
Ginsenoside Rg1 treats chronic heart failure by downregulating ERK1/2 protein phosphorylation.人参皂苷 Rg1 通过下调 ERK1/2 蛋白磷酸化治疗慢性心力衰竭。
In Vitro Cell Dev Biol Anim. 2024 Oct;60(9):1085-1098. doi: 10.1007/s11626-024-00960-w. Epub 2024 Sep 9.
10
Research Progress on Mechanisms and Treatment of Sepsis-Induced Myocardial Dysfunction.脓毒症诱导的心肌功能障碍的机制与治疗研究进展
Int J Gen Med. 2024 Aug 5;17:3387-3393. doi: 10.2147/IJGM.S472846. eCollection 2024.